Vaccine Manufacture and Supply – News and Features

As vaccine technologies evolve, sophisticated analytical tools are needed to support vaccine discovery, development and manufacturing. In this article, we explore the role of chromatography in the vaccine pipeline.

Scott Ripley discusses how overcoming mRNA challenges can help to achieve public health preparedness and long-term manufacturing goals.

According to a study, vaccination campaign budgets for disadvantaged, vulnerable populations need to be raised to reach the maximum health benefit for everyone.

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, is filing patent infringement lawsuits against Pfizer and BioNTech in the United States District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany.

The UK is set to begin a pilot offering eligible patients smaller but equally effective doses of the vaccine used for the UK’s monkeypox outbreak, stretching existing supplies to protect more people.

Technology Networks recently spoke to Drew Buskirk to learn more about peak variation and why it is so important to measure.

Researchers have now developed a special hydrogel that vastly improves the shelf life of vaccines, even without refrigeration.

In this article, we discuss key challenges in vaccine development scale up, highlighting various strategies for overcoming them.

Novel biotechnology platform-based techniques could be more quickly adapted to manufacture vaccines that are more robust, customizable and flexible than traditional approaches.

Researchers set out to find new ways to artificially induce mRNA to respond in ways that could eventually lead to therapeutic outcomes, expanding on the success of the mRNA-based COVID-19 vaccines.